Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frederic Baron
Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis From the Acute Leukemia Working Party of EBMT
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Impact of Growth Hormone (GH) Deficiency and GH Replacement Upon Thymus Function in Adult Patients
PLoS ONE
Multidisciplinary
Related publications
Impact of FAB Classification on Predicting Outcome in Acute Myeloid Leukemia, Not Otherwise Specified, Patients Undergoing Allogeneic Stem Cell Transplantation in CR1: An Analysis of 1690 Patients From the Acute Leukemia Working Party of EBMT
American Journal of Hematology
Hematology
Allogeneic Stem Cell Transplantation Following Relapse Post Autologous Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia: A Retrospective Analysis of 537 Patients From the Acute Leukemia Working Party of the EBMT
American Journal of Hematology
Hematology
Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- A Report From the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Hematopoietic Stem Cell Transplantation From Sources Other Than Matched Related Donors in the Management of Elderly Acute Myeloid Leukemia Patients in First Complete Remission
Journal of Hematopoietic Cell Transplantation
Allogeneic Stem Cell Transplantation for T(3;3)(q21;q26)/Inv(3)(q21;q26) Acute Myeloid Leukemia – Report From the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes of Hematopoietic Stem Cell Transplantation From Unmanipulated Haploidentical Versus Matched Sibling Donor in Patients With Acute Myeloid Leukemia in First Complete Remission With Intermediate or High-Risk Cytogenetics: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Haematologica
Hematology
Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology